Results: Available studies evaluating GP73 in MASLD reported the ability to discriminate MASH from simple steatosis and distinguish patients at different fibrotic stages, but the evidence is still scarce. The gene discussed is GOLM1; the disease is metabolic dysfunction-associated steatohepatitis.